Skip to main content
Top
Published in: PharmacoEconomics 5/2007

01-05-2007 | Original Research Article

The Work Productivity and Activity Impairment Questionnaire for Patients with Gastroesophageal Reflux Disease (WPAI-GERD)

Responsiveness to Change and English Language Validation

Authors: Peter Wahlqvist, Gordon H. Guyatt, David Armstrong, Alessio Degl’Innocenti, Diane Heels-Ansdell, Samer El-Dika, Ingela Wiklund, Carlo A. Fallone, Lisa Tanser, Sander Veldhuyzen van Zanten, Peggy Austin, Alan N. Barkun, Naoki Chiba, Holger J. Schünemann

Published in: PharmacoEconomics | Issue 5/2007

Login to get access

Abstract

Background

A validated productivity questionnaire, the Work Productivity and Activity Impairment questionnaire for Gastroesophageal Reflux Disease (WPAIGERD), exists for Swedish patients with GERD.

Objective

To assess responsiveness to change of the WPAI-GERD and construct validity of the English language version.

Methods

We used the WPAI-GERD in a before-after treatment clinical study of Canadian GERD patients with moderate or severe symptoms treated with esomeprazole 40mg once daily for 4 weeks. We measured productivity variables including GERD-specific absence from work, reduced productivity while at work and reduced productivity while carrying out regular daily activities other than work during the preceding week.

Results

The analysis included 217 patients, of whom 71% (n = 153) were employed. Before treatment, employed patients reported an average 0.9 hours of absence from work due to GERD and 14.0% reduced work productivity (5.8 hours equivalent) in the previous week, as well as 21.0% reduced productivity in daily activities (all patients). After treatment, the corresponding figures decreased to 0.3 hours, 3.0% (1.1 hours equivalent) and 4.9%, respectively. Thus, the improvement (difference from start of treatment) in productivity was 0.6 hours (p = 0.011) for absence from work and 11.0% units (p < 0.001) for reduced work productivity (4.7 hours equivalent, p < 0.001). This translated into an avoided loss of work productivity of 5.3 hours in total on a weekly basis per employed patient. In addition, a 16.1% unit (p < 0.001) improvement for reduced productivity in activities was observed.
Cross-sectional correlation coefficients of WPAI variables with symptoms (range 0.04–0.63) and health-related quality of life (HR-QOL; range 0.02–0.65) supported cross-sectional construct validity. Corresponding change score correlations between WPAI variables and HR-QOL (range 0.0520.56) supported longitudinal construct validity of the WPAI-GERD while low change score correlations between productivity variables and relevant symptoms (range 0.06–0.34) did not.

Conclusion

The English version of the WPAI-GERD showed good cross-sectional construct validity, and results indicated that the WPAI-GERD is responsive to change. Although the results also indicated that longitudinal construct validity may be poor, the overall findings suggest that further study of the instrument remains warranted.
Appendix
Available only for authorised users
Literature
1.
go back to reference Vakil N, Rydén-Bergsten T, Bergenheim K. Systematic review: patient-centred endpoints in economic evaluations of gastroesophageal reflux disease. Aliment Pharmacol Ther 2002; 16: 1469–1480PubMedCrossRef Vakil N, Rydén-Bergsten T, Bergenheim K. Systematic review: patient-centred endpoints in economic evaluations of gastroesophageal reflux disease. Aliment Pharmacol Ther 2002; 16: 1469–1480PubMedCrossRef
2.
go back to reference Burton WN, Morrison A, Wertheimer AI. Pharmaceuticals and worker productivity loss: a critical review of the literature. J Occup Environ Med 2003; 45: 610–621PubMedCrossRef Burton WN, Morrison A, Wertheimer AI. Pharmaceuticals and worker productivity loss: a critical review of the literature. J Occup Environ Med 2003; 45: 610–621PubMedCrossRef
3.
go back to reference Prasad M, Wahlqvist P, Shikiar R, et al. A review of self-report instruments measuring health-related work productivity: a patient-reported outcomes perspective. Pharmacoeconomics 2004; 22 (4): 225–244PubMedCrossRef Prasad M, Wahlqvist P, Shikiar R, et al. A review of self-report instruments measuring health-related work productivity: a patient-reported outcomes perspective. Pharmacoeconomics 2004; 22 (4): 225–244PubMedCrossRef
4.
go back to reference Dent J, El-Serag HB, Wallander MA, et al. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005; 54: 710–717PubMedCrossRef Dent J, El-Serag HB, Wallander MA, et al. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005; 54: 710–717PubMedCrossRef
5.
go back to reference Kennedy T, Jones R. The prevalence of gastro-oesophageal reflux symptoms in a UK population and the consultation behaviour of patients with these symptoms. Aliment Pharmacol Ther 2000; 14: 1589–1594PubMedCrossRef Kennedy T, Jones R. The prevalence of gastro-oesophageal reflux symptoms in a UK population and the consultation behaviour of patients with these symptoms. Aliment Pharmacol Ther 2000; 14: 1589–1594PubMedCrossRef
6.
go back to reference Locke GR, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997; 112: 1448–1456PubMedCrossRef Locke GR, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997; 112: 1448–1456PubMedCrossRef
7.
go back to reference Spechler SJ. Epidemiology and natural history of gastro-oesophageal reflux disease. Digestion 1992; 51 Suppl. 1: S24–S29CrossRef Spechler SJ. Epidemiology and natural history of gastro-oesophageal reflux disease. Digestion 1992; 51 Suppl. 1: S24–S29CrossRef
8.
go back to reference Tougas G, Chen Y, Hwang P, et al. Prevalence and impact of upper gastrointestinal symptoms in the Canadian population: findings from the DIGEST study. Am J Gastroenterol 1999; 94: 2845–2854PubMedCrossRef Tougas G, Chen Y, Hwang P, et al. Prevalence and impact of upper gastrointestinal symptoms in the Canadian population: findings from the DIGEST study. Am J Gastroenterol 1999; 94: 2845–2854PubMedCrossRef
9.
go back to reference Penston JG, Pounder RE. A survey of dyspepsia in Great Britain. Aliment Pharmacol Ther 1996; 10: 83–89PubMedCrossRef Penston JG, Pounder RE. A survey of dyspepsia in Great Britain. Aliment Pharmacol Ther 1996; 10: 83–89PubMedCrossRef
10.
go back to reference Wiklund I. Quality of life in patients with gastroesophageal reflux disease. Am J Gastroenterol 2001;96 Suppl.: S46–S53CrossRef Wiklund I. Quality of life in patients with gastroesophageal reflux disease. Am J Gastroenterol 2001;96 Suppl.: S46–S53CrossRef
11.
go back to reference Henke CJ, Levin TR, Henning JM, et al. Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a health maintenance organization. Am J Gastroenterol 2000; 95: 788–792PubMedCrossRef Henke CJ, Levin TR, Henning JM, et al. Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a health maintenance organization. Am J Gastroenterol 2000; 95: 788–792PubMedCrossRef
12.
go back to reference Dean B, Aguilar D, Crawley JA, et al. Impact of gastroesophageal reflux disease on worker productivity in an employed US population [abstract]. Gastroenterology 2003; 124 Suppl. 1: A505CrossRef Dean B, Aguilar D, Crawley JA, et al. Impact of gastroesophageal reflux disease on worker productivity in an employed US population [abstract]. Gastroenterology 2003; 124 Suppl. 1: A505CrossRef
14.
go back to reference Reilly M, Tanner A, Meltzer EO. Work, classroom, and activity impairment instruments: validation studies in allergic rhinitis. Clin Drug Invest 1996; 11: 278–288CrossRef Reilly M, Tanner A, Meltzer EO. Work, classroom, and activity impairment instruments: validation studies in allergic rhinitis. Clin Drug Invest 1996; 11: 278–288CrossRef
15.
go back to reference Wahlqvist P, Carlsson J, Stålhammar N-O, et al. Validity of a work productivity and activity impairment questionnaire for patients with symptoms of gastro-esophageal reflux disease (WPAI-GERD): results from a cross-sectional study. Value Health 2002; 5: 106–113PubMedCrossRef Wahlqvist P, Carlsson J, Stålhammar N-O, et al. Validity of a work productivity and activity impairment questionnaire for patients with symptoms of gastro-esophageal reflux disease (WPAI-GERD): results from a cross-sectional study. Value Health 2002; 5: 106–113PubMedCrossRef
16.
go back to reference Schunemann HJ, Armstrong D, Degl’Innocenti A, et al. A randomized multi-center trial to evaluate simple utility elicita-tion techniques in patients with gastroesophageal reflux disease. Med Care 2004; 42: 1132–1142PubMedCrossRef Schunemann HJ, Armstrong D, Degl’Innocenti A, et al. A randomized multi-center trial to evaluate simple utility elicita-tion techniques in patients with gastroesophageal reflux disease. Med Care 2004; 42: 1132–1142PubMedCrossRef
18.
go back to reference Ware JE, Snow KK, Kosinski MA. SF-36 health survey manual and interpretation guide. Boston (MA): New England Medical Centre, 1993 Ware JE, Snow KK, Kosinski MA. SF-36 health survey manual and interpretation guide. Boston (MA): New England Medical Centre, 1993
19.
go back to reference Talley NJ, Fullerton S, Junghard O, et al. Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments. Am J Gastroenterol 2001; 96: 1998–2004PubMedCrossRef Talley NJ, Fullerton S, Junghard O, et al. Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments. Am J Gastroenterol 2001; 96: 1998–2004PubMedCrossRef
20.
go back to reference Fairclough DL, Cella DF. Functional assessment of cancer therapy (FACT-G): non-response to individual questions. Qual Life Res 1996; 5: 321–329PubMedCrossRef Fairclough DL, Cella DF. Functional assessment of cancer therapy (FACT-G): non-response to individual questions. Qual Life Res 1996; 5: 321–329PubMedCrossRef
21.
go back to reference Hinkle DE, Jurs SG, Wiersma W. Applied statistics for the behavioral sciences. 2nd ed. Boston (MA): Houghton Mifflin, 1988 Hinkle DE, Jurs SG, Wiersma W. Applied statistics for the behavioral sciences. 2nd ed. Boston (MA): Houghton Mifflin, 1988
22.
go back to reference Curtin F, Schulz P. Multiple correlations and Bonferroni’s correction. Biol Psychiatry 1998; 44: 775–777PubMedCrossRef Curtin F, Schulz P. Multiple correlations and Bonferroni’s correction. Biol Psychiatry 1998; 44: 775–777PubMedCrossRef
23.
go back to reference Brouwer W, Meerding W-J, Lamers L, et al. The relationship between productivity and health-related QOL. Pharmacoeconomics 2005; 23 (3): 209–218PubMedCrossRef Brouwer W, Meerding W-J, Lamers L, et al. The relationship between productivity and health-related QOL. Pharmacoeconomics 2005; 23 (3): 209–218PubMedCrossRef
24.
go back to reference Burke L, Piault E. Patient-reported measures in drug development: FDA perspective. In: Chassany C, Caulin C, editors. Health-related quality of life and patient-reported outcomes: scientific and useful outcome criteria. Paris: Springer-Verlag, 2003: 117–122 Burke L, Piault E. Patient-reported measures in drug development: FDA perspective. In: Chassany C, Caulin C, editors. Health-related quality of life and patient-reported outcomes: scientific and useful outcome criteria. Paris: Springer-Verlag, 2003: 117–122
25.
go back to reference Cohen J. Statistical power analysis for the behavioral sciences. New York: Academy Press, 1977 Cohen J. Statistical power analysis for the behavioral sciences. New York: Academy Press, 1977
26.
go back to reference Lerner D, Adler DA, Chang H, et al. The clinical and occupational correlates of work productivity loss among employed patients with depression. J Occup Environ Med 2004; 46 (6 Suppl.): S46–S55CrossRef Lerner D, Adler DA, Chang H, et al. The clinical and occupational correlates of work productivity loss among employed patients with depression. J Occup Environ Med 2004; 46 (6 Suppl.): S46–S55CrossRef
27.
go back to reference Dean BB, Crawley JA, Reeves JD, et al. The cost of gastroesophageal reflux disease: it’s what you don’t see that counts. J Managed Care Med 2003; 7: 6–13 Dean BB, Crawley JA, Reeves JD, et al. The cost of gastroesophageal reflux disease: it’s what you don’t see that counts. J Managed Care Med 2003; 7: 6–13
28.
go back to reference Stewart WF, Ricci J, Leotta CR. Health-related lost productive time (LPT): recall interval and bias in LPT estimates. J Occup Environ Med 2004; 46: S12–S22PubMedCrossRef Stewart WF, Ricci J, Leotta CR. Health-related lost productive time (LPT): recall interval and bias in LPT estimates. J Occup Environ Med 2004; 46: S12–S22PubMedCrossRef
29.
go back to reference Wahlqvist P, Reilly M, Barkun A. Systematic review: the impact of gastro-oesophageal reflux disease on work productivity. Aliment Pharmacol Ther 2006; 24: 259–272PubMedCrossRef Wahlqvist P, Reilly M, Barkun A. Systematic review: the impact of gastro-oesophageal reflux disease on work productivity. Aliment Pharmacol Ther 2006; 24: 259–272PubMedCrossRef
30.
go back to reference Koopmanschap M, Burdorf A, Jacob K, et al. Measuring productivity changes in economic evaluation: setting the research agenda. Pharmacoeconomics 2005; 23: 47–54PubMedCrossRef Koopmanschap M, Burdorf A, Jacob K, et al. Measuring productivity changes in economic evaluation: setting the research agenda. Pharmacoeconomics 2005; 23: 47–54PubMedCrossRef
31.
go back to reference Torrance G, Feeny D, Furlong W. Visual analog scales: do they have a role in measurement of preferences for health states? Med Decis Making 2001; 21: 329–334PubMed Torrance G, Feeny D, Furlong W. Visual analog scales: do they have a role in measurement of preferences for health states? Med Decis Making 2001; 21: 329–334PubMed
Metadata
Title
The Work Productivity and Activity Impairment Questionnaire for Patients with Gastroesophageal Reflux Disease (WPAI-GERD)
Responsiveness to Change and English Language Validation
Authors
Peter Wahlqvist
Gordon H. Guyatt
David Armstrong
Alessio Degl’Innocenti
Diane Heels-Ansdell
Samer El-Dika
Ingela Wiklund
Carlo A. Fallone
Lisa Tanser
Sander Veldhuyzen van Zanten
Peggy Austin
Alan N. Barkun
Naoki Chiba
Holger J. Schünemann
Publication date
01-05-2007
Publisher
Springer International Publishing
Published in
PharmacoEconomics / Issue 5/2007
Print ISSN: 1170-7690
Electronic ISSN: 1179-2027
DOI
https://doi.org/10.2165/00019053-200725050-00003

Other articles of this Issue 5/2007

PharmacoEconomics 5/2007 Go to the issue